FDA Approves Next-Gen Inspire V Therapy System for Sleep Apnea
The FDA has approved the next-generation Inspire V therapy system for the treatment of moderate to severe obstructive sleep apnea.
Tag: inspire medical
FDA Approves Next-Gen Inspire V Therapy System for Sleep Apnea
The FDA has approved the next-generation Inspire V therapy system for the treatment of moderate to severe obstructive sleep apnea.
Read More
Inspire’s Sleep Apnea Therapy Meets New EU Standards
Inspire Medical’s sleep apnea treatment has received CE mark certification under the EU’s updated and more stringent Medical Device Regulation.
Read More
Key Component of Inspire Therapy for Sleep Apnea Recalled
The recall addresses a defect in the Inspire IV implantable pulse generator that may cause malfunctions and necessitate revision surgery for patients.
Read More
Inspire Medical Sleep Apnea Device Sales Soared
Inspire Medical announced Tuesday that its 2021 revenue would be between $233 million and $233.4 million, a robust increase of about 102% over the previous year.
Read More